zaltrap

Generic: ziv-aflibercept

Labeler: sanofi-aventis u.s. llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name zaltrap
Generic Name ziv-aflibercept
Labeler sanofi-aventis u.s. llc
Dosage Form SOLUTION, CONCENTRATE
Routes
INTRAVENOUS
Active Ingredients

aflibercept 100 mg/4mL

Manufacturer
sanofi-aventis U.S. LLC

Identifiers & Regulatory

Product NDC 0024-5840
Product ID 0024-5840_14431dcb-cda7-4ae4-aa2b-6480d6ac459f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA125418
Listing Expiration 2026-12-31
Marketing Start 2012-08-03

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00245840
Hyphenated Format 0024-5840

Supplemental Identifiers

RxCUI
1723187 1723189 1723193 1723194
UNII
15C2VL427D
NUI
N0000193543 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zaltrap (source: ndc)
Generic Name ziv-aflibercept (source: ndc)
Application Number BLA125418 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/4mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0024-5840-01) / 4 mL in 1 VIAL
source: ndc

Packages (1)

Ingredients (1)

aflibercept (100 mg/4mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "14431dcb-cda7-4ae4-aa2b-6480d6ac459f", "openfda": {"nui": ["N0000193543", "N0000193542"], "unii": ["15C2VL427D"], "rxcui": ["1723187", "1723189", "1723193", "1723194"], "spl_set_id": ["f6725df6-50ee-4b0a-b900-d02ba634395d"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["sanofi-aventis U.S. LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0024-5840-01)  / 4 mL in 1 VIAL", "package_ndc": "0024-5840-01", "marketing_start_date": "20120803"}], "brand_name": "ZALTRAP", "product_id": "0024-5840_14431dcb-cda7-4ae4-aa2b-6480d6ac459f", "dosage_form": "SOLUTION, CONCENTRATE", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "0024-5840", "generic_name": "ziv-aflibercept", "labeler_name": "sanofi-aventis U.S. LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZALTRAP", "active_ingredients": [{"name": "AFLIBERCEPT", "strength": "100 mg/4mL"}], "application_number": "BLA125418", "marketing_category": "BLA", "marketing_start_date": "20120803", "listing_expiration_date": "20261231"}